The Greens have released the costings of their plan to legalise and tax cannabis in Australia.

The proposal also outlines the production and sale of recreational cannabis in Australia through a tightly regulated model, including establishing a new agency, the Australian Cannabis Agency, to act as the sole wholesaler between producers and retail outlets.

It would also set prices and be responsible for issuing production and sales licences.

There are about 25 cannabis-related stocks trading on the ASX, though most are focused on medical or cosmetic applications.

Here’s Stockhead’s list of which stocks hold Australian cannabis licences.

Scroll down for a full list of ASX pot stocks.

Costings from the federal Parliamentary Budget Office says legalising marijuana in Australia would increase the fiscal balance by $3.5 billion and increase the underlying cash balance by $3.3 billion over the Budget forward estimates period.

Taxes would lead to a surge in revenue of over $4.5 billion, with costs running at just over $1 billion.

Among other aspects of the proposal which would see sales of recreational cannabis restricted to individuals over 18 years of age, with no restrictions on the amount individuals could purchase, it assumes the average recreational cannabis consumer purchases three grams per week.

With the average joint containing approximately 0.32 grams of cannabis, that’s enough marijuana to make about 10 joints a week.

While that sounds like a lot, the plan put forward by the Greens is based on analysis of countries and states where legalisation of recreational cannabis has occurred, and acknowledges that the actual outcomes may differ significantly due to differences in policy specifications and market characteristics between Australia and overseas.

Also under the proposal, sales to overseas visitors would be permitted and individuals would be permitted to grow up to six plants for personal use.

Here is a list of ASX pot stocks:

ASX Code Name 3-month price change (Jan-Mar) Market Cap (end of Mar)
ZLD ZELDA 0.075 79.31M
SCU STEMCELL UNITED -0.002849002849 15.40M
RGI ROTO-GRO -0.0126582278481 32.68M
QBL QUEENSLAND BAUXITE -0.259259259259 63.75M
MMJ MMJ PHYTOTECH -0.197802197802 79.52M
MXC MGC PHARMA -0.0752688172043 95.03M
MDC MEDLAB CLINICAL -0.214285714286 131.05M
LSH LIFESPOT HEALTH 0.0384615384615 10.87M
THC HYDROPONICS -0.215827338129 68.64M
EVE EVE INVESTMENTS -0.333333333333 21.99M
ESE ESENSE-LAB -0.431034482759 13.31M
EXL ELIXINOL GLOBAL (*floated Jan 2018) 0.71 174.98M
CPH CRESO PHARMA -0.193548387097 83.22M
CP1 CANNPAL ANIMAL 0.0975609756098 21.88M
CAN CANN GROUP 0.0454545454545 429.80M
BOT BOTANIX PHARMACE 0.617647058824 78.42M
BDA BOD AUSTRALIA -0.0128205128205 20.45M
AC8 AUSCANN GROUP 0.968944099379 437.96M
ATP ATLAS PEARLS -0.148148148148 10.27M
AEB ALGAE.TEC 0 19.87M
1PG 1-PAGE 0 25M

 

This article first appeared on Business Insider Australia, Australia’s most popular business news website. Read the original article. Follow Business Insider on Facebook or Twitter.